GlassScriptPhysician profile
Aiyesha Stiles
NPI 1306332952
$3,330.15
in general payments reported to CMS, 2019-2025
17 companies · $17.52 in 2025
The $17.52 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,016 · 2022: $1,226 · 2023: $908 · 2024: $162 · 2025: $17.52.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,088.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,087.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,693.11 | 2021-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $366.77 | 2021-2023 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $253.62 | 2022-2023 | |
| Alkermes, INC. | $152.30 | 2022 | |
| Evoke Pharma, INC. | $143.69 | 2022 | |
| Glaxosmithkline, LLC. | $143.67 | 2021 | |
| Novo Nordisk INC | $133.40 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $125.00 | 2024 | Spravato |
| Supernus Pharmaceuticals, INC. | $124.99 | 2023 | Qelbree |
| Lilly USA, LLC | $58.57 | 2021-2023 | Trulicity, Mounjaro |
| Neurocrine Biosciences, INC. | $34.50 | 2024-2025 | Ingrezza |
| Bausch Health US, LLC | $21.09 | 2022 | |
| Vanda Pharmaceuticals INC. | $20.51 | 2024 | Fanapt |
| Pfizer INC. | $19.63 | 2021 | |
| Lundbeck LLC | $15.69 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $12.49 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $11.12 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aiyesha Stiles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.